A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Clinical trial NCT07673887 · RECRUITING
Trial details
- NCT number
- NCT07673887
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2031-02-28
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.